Baird’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$5.85M Sell
64,824
-334,753
-84% -$28.8M 0.06% 305
2014
Q4
$32.3M Sell
399,577
-3,549
-0.9% -$280K 0.34% 94
2014
Q3
$30.2M Sell
403,126
-7,806
-2% -$568K 0.42% 82
2014
Q2
$28.2M Sell
410,932
-13,084
-3% -$891K 0.4% 84
2014
Q1
$29.7M Buy
424,016
+12,795
+3% +$890K 0.43% 71
2013
Q4
$27.5M Sell
411,221
-17,252
-4% -$1.05M 0.47% 35
2013
Q3
$22.3M Buy
428,473
+393,584
+1,128% +$20M 0.42% 51
2013
Q2
$1.65M Buy
+34,889
New +$1.59M 0.03% 456

Other funds holding CAH

Baird's CAH Position: Q1 2015 in Review

Baird reduced its Cardinal Health (CAH) stake by 84% in Q1 2015, selling an estimated $28.8M and leaving 64,824 shares worth $5.85M. The position accounts for 0.06% of the portfolio, ranked #305.

Baird first reported a position in CAH in Q2 2013 and has held it in 8 quarters since. The position peaked at $32.3M in Q4 2014. 731 funds tracked by Wall St. Rank hold CAH as of Q1 2015.

  • Baird held 64,824 shares of Cardinal Health worth $5.85M as of Q1 2015.
  • Baird sold 334,753 Cardinal Health shares in Q1 2015, an estimated $28.8M.
  • Cardinal Health made up 0.06% of Baird's portfolio in Q1 2015, its #305 holding.
  • Baird first reported a position in Cardinal Health in Q2 2013 and has held it in 8 quarters since.
  • Baird's Cardinal Health position peaked at $32.3M in Q4 2014.
  • 731 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.